Canopy Growth Corporation Share Price Nasdaq

Equities

CGC

CA1380357048

Pharmaceuticals

Market Closed - Nasdaq 01:30:00 08/05/2024 am IST 5-day change 1st Jan Change
9.48 USD -2.47% Intraday chart for Canopy Growth Corporation -36.29% +85.52%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 321M 234M 19.51B Sales 2025 * 303M 220M 18.41B Capitalization 974M 709M 59.21B
Net income 2024 * -491M -358M -29.84B Net income 2025 * -121M -88.1M -7.35B EV / Sales 2024 * 4.37 x
Net Debt 2024 * 427M 311M 25.95B Net Debt 2025 * 403M 293M 24.49B EV / Sales 2025 * 4.55 x
P/E ratio 2024 *
-2.22 x
P/E ratio 2025 *
-10.2 x
Employees 1,621
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.8%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.47%
1 week-36.29%
Current month-36.29%
1 month-6.88%
3 months+119.44%
6 months+61.39%
Current year+85.52%
More quotes
1 week
9.35
Extreme 9.35
12.97
1 month
6.09
Extreme 6.09
14.92
Current year
2.76
Extreme 2.755
14.92
1 year
2.76
Extreme 2.755
19.20
3 years
2.76
Extreme 2.755
269.60
5 years
2.76
Extreme 2.755
564.97
10 years
2.76
Extreme 2.755
592.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 01/18/01
Director of Finance/CFO 52 02/19/02
Investor Relations Contact - 01/16/01
Members of the board TitleAgeSince
Chief Executive Officer 60 01/18/01
Chairman 69 31/20/31
Director/Board Member 67 31/20/31
More insiders
Date Price Change Volume
07/24/07 9.48 -2.47% 12,568,283
06/24/06 9.72 -5.08% 16,848,867
03/24/03 10.24 -0.97% 15,724,844
02/24/02 10.34 -9.62% 29,703,467
01/24/01 11.44 -23.12% 55,264,353

Delayed Quote Nasdaq, May 08, 2024 at 01:30 am IST

More quotes
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
14
Last Close Price
13.31 CAD
Average target price
7.725 CAD
Spread / Average Target
-41.96%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW